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Ontogeny of angiotensin II receptors, types 1 and 2, in ovine mesone-
phros and metanephros. By RNAse protection assay, hybridization histo-
chemistry, and in vitro autoradiography it was shown that both mRNA and
protein for AT1 and AT2 receptors were present in ovine fetal meso- and
metanephroi at 40 days of gestation (term 150 days). AT1 mRNA was
localized to presumptive mesangial cells of glomeruli at 40-, 75-, 131-
gestational-day-old fetuses and two-day-old lambs, in addition to being
widely present in interstitial cells of the cortex and medulla, once these
zones formed (60 days). By two days after birth the medullary AT1
distribution was confined to the inner stripe of the outer medulla. AT2
mRNA was present in peripheral interstitial/tissue of the mesonephros,
and interstitial tissue surrounding developing glomeruli, but not the
outermost nephrogenic mesenchyme in the metanephros from 40 to 131
days (the period of active nephrogenesis). In addition, AT2 mRNA was
localized to epithelial cells of the macula densa in metanephroi (40 to 131
gestional days) during, but not after completion, of nephrogenesis. These
studies suggest that angiotensin II (Ang II) could have differentiating
effects, via AT1 receptors, from very early in development. The unique
epithelial site of AT2 expression in the macula densa raises the possibility
that Ang II may play a role in the invariant positioning of the macula
densa at the pole of its glomerulus, via this receptor.
There is great interest in the development of all components of
the renin-angiotensin system (RAS) in the fetus for two main
reasons. The first is that the use of several inhibitors of angioten-
sin converting enzyme (ACE) in pregnant women, which cross the
placenta, has been associated with substantial morbidity and
mortality of the fetus [1, 2]. The second reason is that there is a
growing body of evidence, from studies in rodents, that inhibition
of the action of the RAS, during kidney development, leads to
impairment of normal kidney morphology [3], and may be asso-
ciated with an increased incidence of hypertension in the adult [4,
5].
It has been held, widely, that all components of the RAS are
being expressed at a high rate during fetal life; the system is more
active than in the adult [reviewed in 6]. It has also been argued [6,
7] that the major role of the fetal RAS is different to that of the
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adult. While the RAS in the adult functions in the conservation of
body sodium and fluid, and the maintenance of blood pressure,
the fetal RAS seems to be essential for normal sodium and water
loss in the urine via an effect on the maintenance of glomerular
filtration rate (GFR) and urine flow [6, 7]. The fetal kidney is
relatively underperfused and so behaves as does the stenosed
adult kidney, in which the RAS is also important for GFR
maintenance [6, 7]. Normal urine output by the fetus is essential
for the maintenance of amniotic fluid volume, and normal fetal
development [8, 9]. Oligohydramnios, consequent upon fetal
renal failure, is associated with increased mortality and morbidity
of the fetus [8, 9].
Early in development there are two sets of fetal kidneys, the
mesonephroi and the metanephroi [10]. In the human fetus the
mesonephros begins to form at four to five gestational weeks,
reaches maximal development by eight gestational weeks, and has
degenerated completely by 16 gestational weeks, while the meta-
nephric kidney is induced from five gestational weeks [11]. In the
sheep the mesonephros first appears by 16 to 18 gestational days,
reaches maximal development by 27 to 30 gestational days, and is
completely regressed by about 54 gestational days, where term is
145 to 150 gestational days [12]. It is a segmental kidney of
approximately 100 nephrons formed on either side from the
nephrogenic mesenchyme and the accompanying Wolffian duct
and develops in a cranial to caudal manner [13].
The metanephros or permanent kidney develops from a bud of
the Wolffian duct and its cap of nephrogenic mesenchyme in the
caudal regions of the sheep embryo from about 27 days of
gestation [14J. The bud becomes the ureter and its branches the
collecting ducts. The growing tips of these branches induce the
overlying mesenchyme into condensates that transform into epi-
thelial vesicles, and subsequently the comma- and S-shaped
bodies, the precursors of the nephron.
Mesonephric kidneys of human and ovine fetuses [13, 14]
contain mRNA and protein for renin, angiotensinogen and ACE.
The presence of receptors, in mesonephroi, however, has not
received much attention except in rats and mice [15—17].
In the human and sheep there are two types of angiotensin II
receptors described so far (AT1 and AT2), while rodents appear to
have at least three (AT1A, AT1B, AT2) [18, 19]. The ontogeny of
the receptor mRNA has been studied in the ovine fetus, in which
higher levels of AT2 mRNA have been found in metanephroi of
fetuses at 60 to 90 days of gestation than in later fetal kidneys [20].
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The AT1 receptor mRNA in the metanephros was fairly constant
over the last third of gestation and decreased by 10 days after birth
[21]. No studies, however, have been done on the localization of
the AT1 and AT2 receptor mRNA in the fetal sheep. The aims of
this study were twofold: (1) to establish the ontogeny of gene
expression of the AT1 and AT2 receptors from 27 to 60 days of
gestation in the ovine fetus; and (2) to study the localization of
gene expression in the metanephric kidney throughout the whole
developmental period. In addition in vitro autoradiography was
used to show that any mRNA detected was translated into
protein.
METHODS
Animals
Pregnant cross-bred Merino ewes (N = 14; 22 fetuses; 1
quadruplet, I triplet, 6 twins and 3 singletons) of known mating
dates (term = 147 5 gestational days) and 3 two-day-old lambs
were sacrificed with an intravenous bolus dose of sodium barbi-
tone (Lethobarb, Arnolds, Reading, UK). For hybridization his-
tochemistry the whole fetus (N = 3; 27 days) or individual
mesonephroi and metanephroi (N = 4, 41 days) were collected
(using a dissecting microscope if necessary). In vitro autoradiog-
raphy was carried out on the mesonephroi of three fetuses at 40 to
43 gestational days, and metanephroi of three fetuses at each of 40
to 43 gestational days, 60 to 64 gestational days, and 100 to 106
gestational days. In addition hybridization histochemistry was
performed on metanephroi from three fetuses each at 75 to 77
gestational days and 120 to 131 gestational days, as well as from
three lambs. For the RNAse protection assay there was one fetus
at 40 to 43 gestational days, and three each at 60 to 64, 100 to 106,
and 140 to 141 gestational days. For simplicity these ages are
plotted as 40, 60, 100, 140.
Tissue preparation for hybridization histochemistry
Lamb kidneys and fetal mesonephroi and metanephroi were
dissected out and immersion fixed in 4% paraformaldehyde in 0.1
M phosphate buffer pH 7.2, dehydrated and processed routinely
through solvents to paraffin.
Probes
Ovine AT1 and AT2 cDNAs were generously provided by Dr.
J.E. Robillard and have been described previously [20, 211. cRNA
probes were prepared using the Promega riboprobe kit (Promega,
Madison, WI, USA) and [a-35S]UTP (100 CI mmol1; Bresatec,
Thebarton, Australia). Before hybridization histochemistry, the
probes were hydrolysed according to the method of Cox et al [22].
Before use, both the antisense and sense (negative control)
riboprobes were diluted to a concentration of 0.02 ng/jd in
hybridization buffer consisting of 50% deionized formamide, 20%
dextran sulphate, 10% 10 >< salts (3 M NaCI, 100 mvt Na2HPO4,
pH 6.8, 100 m'vi Tris-HC1, pH 7.5, 50 mtvi EDTA, pH 8.0, 0.2%
BSA, 0.2% Ficoll 400, 0.2% polyvinyl pyrolidone), 3.5% tRNA
(20 mg/mI), 1% DYE.
Hybridization histochemistry
The hybridization histochemistry procedure has been published
elsewhere [23]. Briefly, 4 tm section were cut and mounted on
silanated slides, dried, dewaxed, rehydrated, rinsed in autoclaved
"P" buffer (50 ms'i Tris-HCI, pH 7.5, 5 m'vi EDTA), digested with
pronase E (125 ig/m1 "P" buffer) for 10 minutes at 37°C to
enhance the hybridization signal, rinsed in 0.2 M phosphate buffer,
pH 7.2, then post-fixed in 4% paraformaldehyde for 10 minutes at
room temperature and rinsed again in phosphate buffer. The
sections were then sequentially dehydrated through graded alco-
hols and air dried. Hybridization histochemistry was performed by
covering the sections with approximately 40 1 diluted riboprobe
and an overnight incubation in a sealed humidified chamber at
50°C. The slides were thoroughly washed in formamide buffer
(50% formamide, 40% distilled water and 10% 10 >< salts) at 50°C
to remove the viscous dextran, rinsed copiously in RNase A buffer
(0.5 M NaCI, 10 mrvi Tris-HCI, pH 7.5, 50 ms'i EDTA, pH 8) at
37°C and digested with RNase A (150 jLg/ml; Sigma-Aldrich) for
two hours at 37°C to remove the unhybridized riboprobe. Follow-
ing the digestion, the sections were washed twice at 65°C in 2 X
SSC for 30 minutes each, rinsed in water to remove the salts,
dehydrated and air dried. Triplicate sections were hybridized in
each run, and the whole procedure was performed on three
separate occasions. Adjacent sections were analyzed using a sense
probe as a negative control, but in no instance was a specific signal
detected.
Liquid emulsion autoradiography
Slides were exposed to a high sensitivity Fuji phosphor imaging
plate (BAS III) overnight at room temperature. Images from the
plates were scanned on a Fujix BAS 2000 scanner and the signals
obtained were used as a guide to subsequent exposures with liquid
emulsion. Slides were dipped in KS emulsion (Ilford, Essex, UK)
diluted 1:1.5 with distilled water (vol/vol) and exposed at room
temperature for 10 to 12 days. Autoradiographs were developed
at room temperature for one minute in D19 (Kodak), rinsed in
water, fixed in Hypam (Ilford) diluted 1:4 (vol/vol) and stained
with hematoxylin and eosin.
Image acquisition
Hybridization histochemistry micrograph images were gener-
ated on a Nikon Microphot microscope (Nikon, Australia) linked
to a Sony 930P video camera (Sony, Australia) and the resulting
images digitized and processed using the microcomputer imaging
device (MCID) M2 software (Imaging Research Inc., St Ca-
tharines, Canada). Under low magnification, silver grains are not
visible readily, especially at low levels of mRNA expression. To
overcome this problem, images where captured at the silver grain
level and others were focused on cell morphology. The silver grain
information was then extracted and accented by the application of
filters and a binarization point operator resident in the MCID M2
software package. Subsequently the enhanced grain image was
recombined with the morphological image (Coghian JP, Butkus
A, manuscript in preparation).
Receptor binding images were generated using a Xillix Micro-
Imager high-resolution digital intergrating camera. With the M2
system the camera is used as a 10 bit device, yielding 1024 grey
levels. The images, were printed on a Fujix BAS HG-printer
(Berthold, Australia Pty Ltd, Victoria, Australia).
mRNA quantitation
Tissue was frozen immediately in liquid nitrogen and stored at
— 80°C until used, except for tissue from 40 to 43 days, which was
collected into buffer and extracted immediately. Total RNA was
isolated using the method of Chirgwin et al [24] except for 40 days
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mesonephros and metanephros samples where the method of
Chomeznski and Sachi [25) was employed due to the small size. A
solution hybridization nuclease protection assay using 10 g of
total cellular RNA was performed to determine AT1 and AT2
mRNA levels using GAPDH as an internal control. [32P]UTP
(Dupont, Boston, MA, USA) labeled antisense RNA probes were
synthesized using the Promega riboprobe kit (Promega). The
ovine AT1 and AT7 probes were as previously described except
that the AT2 plasmid was linearized at an internal KpnI site
resulting in a specific probe 510 nt in length. The ovine GAPDH
probe was 294 nt in length. Total RNA was annealed with
approximately I x I0 cpm of each probe for 70 minutes in 30 d
of hybridization buffer [25 m Pipes (6.8), 1 M NaCI, 1 mt EDTA]
at 85°C. The samples were then digested with 200 U Si nuclease
(Promega) according to the suppliers instructions for one hour at
37°C. The digested RNA was precipitated with isopropanol and
analyzed by electrophoresis in a 4% non-denaturing polyacryl-
amide gel. After electrophoresis, gels were dried, exposed on a
phosphoimaging plate and quantitation performed using a Fuji
BAS 2000 Bioimaging Analyser (Berthold Australia).
In vitro autoradiographic localization of angiotensin receptor
binding
To localize AT1 and AT2 receptors and correlate these receptor
proteins with the expression of their mRNAs in the mesonephros
and metanephros of fetal sheep kidneys, Ang II receptor binding
studies were performed on the mesonephros and metanephros
from 40-, 60- and 100-gestational-day-old fetal lambs using in vitro
autoradiography as described previously [26]. Frozen sections (20
tm) were cut on an Ames cryostat at —20°C thaw mounted onto
gelatinized slides and dehydrated overnight under reduced pres-
sure at 4°C. Sections were preincubated for 15 minutes in 10 mM
sodium phosphate buffer (pH 7.4), followed by a one hour
incubation in a fresh volume of the same buffer containing 0.2%
bovine serum albumin, 0.3 ms bacitracin, and 0.2 iCi/ml 125J
[Sar1, Tie8] Ang II to determine total Mg II receptor binding.
Nonspecific binding was determined by adding I j.M of unlabeled
Mg II to the buffer. To determine AT1 and AT2 receptor binding,
either the AT1 receptor antagonist, losartan (10 tiM), or the AT2
receptor antagonist, PD 123319 (10 ELM), was added into parallel
incubations [26]. Moreover, in separate incubations both losartan
and PD 123319 were added to examine if other additional Ang II
receptor subtype was present in the mesonephros and metane-
phros. After incubation, sections were washed four times for one
minute in ice cold buffer, dried under a stream of cold air and
exposed to Agfa Scopix CR3BX-ray film at room temperature for
13 days. A set of radioactive standards were included in each
cassette. Following exposure, films were processed and the optical
densities were quantified using a microcomputer imaging device
(MCID Imaging system) coupled to an IBM AT computer. A
calibration curve of optical density versus radioactivity density was
constructed by the computer program using the standards. This
allowed the remapping of the autoradiographs into disintegra-
tions per minute per square millimeter (dpm/mm2) [26].
RESULTS
The results of the RNAse protection assay are shown in Figure
1. Although no statistical evaluation can be made from just one
sample (from 2 organs) of RNA from the mesonephros and
metanephros at 40 days of gestation, it is apparent that mRNA for
both AT1 and AT2 receptors was present in these tissues. By
ANOVA there was a significant increase (P < 0.05) in AT1
mRNA between 60 and 100 days, with no change thereafter. AT2
mRNA levels were comparable at 60 to 100 days and below the
level of detection at 140 days of gestation. No interpretation of the
relative levels of AT1 and AT2 mRNA was attempted, as the
probes used were not necessarily of the same specific activity, nor
is it known if the hybridization efficiency of the two probes is
equal.
Expression of AT1 and AT2 receptor mRNAs in the
mesonephros
At gestational day 27, AT1 receptor mRNA was detected
throughout the interstitium including the peripheral regions and
in the large mesonephric glomeruli, typically located in a central
axial position, indicative of a mesangial cell location, while AT7
receptor mRNA was localized to the peripheral interstitium of the
mesonephros only (Fig. 2 A and B, respectively). At 40 days of
gestation the AT1 receptor mRNA was strongly detected in the
central axial regions of the large mesonephric glomeruli (Fig. 2C).
AT2 receptor mRNA was again detected in the peripheral inter-
stitium, particularly surrounding the Wolffian duct (Fig. 2D). AT2
receptor mRNA was also detected in the walls of blood vessels,
especially those situated in the cranial end of the mesonephros.
Expression of AT1 and AT2 receptor mRNAs in the
metanephros
The nephrogenic mesenchyme was not specifically labeled for
either AT1 or AT2 receptor mRNA at any stage throughout
development.
At a gestational age of 40 days the AT1 receptor mRNA was
localized to developing glomeruli (Fig. 3A) predominantly in an
axial and thus most likely a mesangial position. Glomeruli specif-
ically labeled for AT1 mRNA contained developing glomerular
capillary tufts. Earlier stages of glomerular formation, for example
the lower limb of S-shaped bodies were not labeled for AT1
receptor mRNA. Labeling was also found in the interstitium,
specifically on interstitial cells, particularly in the medullary
region. AT2 receptor mRNA was localized to the interstitium,
particularly the interstitial cells surrounding comma and S-shaped
nephron structures and to the vascular pole of developed giomer-
uli, at the macula densa region (Fig. 3B).
At 75 days of gestation age the localization of both AT1 and
AT2 receptor mRNA was similar to that at earlier stages. AT1
mRNA was localized to the axial regions of glomeruli and the
interstitium (Fig. 3C) and particularly throughout the medulla
and medullary rays in the cortex (Fig. 3E). At a higher magnifi-
cation the intense AT2 receptor mRNA labeling at the vascular
pole of glomeruli was localized to the macula densa (Fig. 3D).
With the AT2 mRNA probe, more diffuse labeling of interstitial
cells surrounding the developing nephron structures and extend-
ing into the meduliary rays was also observed.
At a gestational age of 131 days the nephrogenie zone of the
kidney was decreased in size. The cortical zone was increased in
size and contained layers of well developed giomeruli and tubules.
The outer medulla remained tubule deplete. AT1 receptor mRNA
was clearly localized to the central mesangial regions of glomeruli
and to the interstitial cells surrounding tubules throughout both
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Fig. 1. Renal AT1 and AT2 mRNA levels throughout gestation. (A) Representative autoradiograph; exposure time 24 hours for AT1 and AT2, eight
hours for GAPDH. (B) Quantitation of mRNA levels was determined using a Fuji BAS 2000 Bioimaging Analyser. AT1 and AT2 mRNA levels (left
and right panels, respectively) were normalized to GAPDH levels and expressed as mean SEM.
the cortex, particularly in the medullary rays, and the medulla (not
shown). AT2 receptor mRNA was still observed as hot spots on
macula densae and more diffusely in the interstitium surrounding
the developing glomeruli and within the upper parts of the
medullary rays.
By two days after birth labeling for AT2 receptor mRNA was
absent throughout the kidney. AT1 receptor mRNA was promi-
nent in mesangial positions of glomeruli and specifically located in
the interstitial cells of the inner stripe of the outer medulla (Fig.
3F).
Expression of AT1 and AT2 receptor binding in the
mesonephros and metanephros
The distributions of AT1 mRNA and protein are well corre-
lated, and the medullary distribution is wider in the fetus than in
the neonatal lamb. The proportions of AT1 and AT2 receptors in
the cortex and medulla are depicted in Figure 4. Specific Ang 11
receptor binding was detected in moderate density in both
mesonephros and metanephros of the 40 days and the metane-
phros of 60 and 100 fetal days. At 40 days, the mesonephros has
no medulla, and the cortex and medulla are not clearly distin-
guishable in the metanephros. Therefore, the data represent the
binding in the whole mesonephros or metanephros. Binding in the
whole mesonephros was approximately 60% to that in the meta-
nephros. In both meso- and metanephros approximately 65% of
the binding was of the AT2 subtype, and 35% to the AT1 subtype.
At 60 days and 100 days of gestation, the cortex and medulla are
identifiable. While there were no marked alterations in the
proportions of AT1 or AT2 receptors in the cortical region, the
proportion of the AT1 receptor binding was increased while that
of the AT2 receptor binding fell throughout the medulla (Fig. 4).
No other additional Ang II receptor subtype was detected in
either mesonephros or metanephros at 40, 60 and 100 days of
gestation, as combined losartan and PD 123319 completely abol-
ished the radioligand binding.
Figure 5 shows the distribution of AT1 and AT2 receptors in
one representative ovine fetal kidney at 100 days.
DISCUSSION
The major findings in this study are that both AT1 and AT2
mRNAs are present in the mesonephros at 27 and 40 days of
gestation, and in the metanephros from 40 days until 131 days,
and that AT2 mRNA is localized to a unique epithelial site, the
macula densa, during, but not after, the period of active nephro-
genesis. By 40 days it was possible to show this mRNA translated
into protein. Therefore, Ang II could act on both AT1 and AT2
receptors to potentially influence both renal development and
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Fig. 2. Localization of AT1 and AT2 receptor mRNA in the mesonephros of the ovine fetus at 27 and 41 days gestation. Sections were analyzed by
hybridization histochemistry as described in the Methods section. Videomicrographs of a 27 days mesonephros hybidized with an antisense riboprobe
to AT1 (A) and AT2 (B) mRNA. AT1 mRNA (A) expression is observed throughout the interstitium, particularly at the periphery (arrow) and in the
large immature glomeruli (g). AT2 mRNA (B) expression is confined to the peripheral interstitium (arrows) (X 100). At 41 days gestation, intense AT1
mRNA (C, left panel) expression is localized to the immature glomeruli (g), while the AT2 mRNA (D, left panel) is distributed throughout the
interstitium surrounding the Woiffian duct (wd). Hybridization with sense AT1 (C, right panel) and AT2 (D, right panel) probes show a low level
background (X40).
renal function from this early stage of gestation, as renin, angio-
tensinogen and ACE are also expressed in the kidneys at this time
[13]. The distribution of AT1 receptor mRNA and protein was
much more widespread in the fetus than in the adult, particularly
as it occurred in the medullary rays and whole width of the
medulla, instead of being confined to the inner stripe of the outer
medulla.
By two days after birth AT1 mRNA distribution has assumed a
similar distribution to that found in the adult human and rat by
receptor binding studies [16, 27—29] or by hybridization histo-
chemistry [15, 30], and AT2 mRNA is absent. In general the
distribution AT1 and AT2 mRNAs in fetal kidneys is similar to
that found in mouse [17], rat [151 and human [301, with the
exception that the macula densa location of AT2 receptors has not
been particularly noted in these other species. In one study on the
human fetal kidney [30], AT2 mRNA was noted to be at the pole
of the glomeruli, but the structure was not identified as the macula
densa.
The evidence for an effect of Ang II on renal morphogenesis
comes largely from studies in post-natal rats treated with a
converting-enzyme inhibitor, or blockers of AT1 (losartan) or AT2
(PD 123319) receptors [3—51, or from a knockout of the angio-
tensinogen gene [311 or the ACE gene [32]. While there is
controversy about the role of Ang II in the development of the
glomeruli, there is consensus that the lack of angiotensin 11 action
on an AT1 receptor produces gross damage to tubules and
vascular structures, particularly in the inner stripe of the outer
medulla, which is consistent with failure of maturation and
descent of loops of Henle from mid and outer cortical glomeruli.
Thus, the presence of the AT1 receptors in the area of subsequent
formation of loops of Henle imply a role of Ang II, via the AT1
receptor, in the formation and maturation of these structures. The
ATIA receptor gene has been deleted in mice by homologous
recombination without noticeable renal abnormalities [33]. How-
ever, in mice there is also an ATIB receptor that may replace any
deficit from lack of the ATIA receptor.
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Fig. 3. Localization of sheep AT1 or AT2 receptor mRNA in the metanephros. For all panels, antisense riboprobe is depicted in the left panels and sense
riboprobe on the right panels. A) Videomicrograph of a 40-day fetal metanephros Section hybridized with AT1 receptor riboprobe. AT1 mRNA is
expressed strongly in the mesangial region of the glomeruli (g), and to a lesser extent in the interstitium surrounding the developing nephrons. There
is no expression of the receptor in the nephrogenic zone (nz). tB) 1-lybridization with an AT2 antisense riboprobe, shows that the AT2 mRNA is
expressed in the maeula densa (md) and the interstitium (arrowheads; x 100). (C) At 75 days gestation, the AT1 mRNA is localized to the axial region(presumptive mesangial cells) of the glomerulus (g), and the interstitial cells. (D) AT2 mRNA is clearly expressed in the macula densa (md) (X400).
(E) At low magnification (E), it is notable that there is an even distribution of AT1 mRNA throughout the interstitium is surrounding developing loops
of Henle (lh) the medullary rays (mr) and the glomeruli (g). In the two-day-old lamb (F), high levels of AT1 mRNA are observed in the inner stripe
of the outer medulla (isom), but little above background in outer stripe of the outer medulla (osom) (X40). In each case, hybridization with the
corresponding sense probe indicates the low level background.
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Fig. 4. Percentage of the AT1 and AT2 receptor binding in the mesone-
phros and metanephros of the developing fetal ovine kidney. Symbols are:() cortex; (I) medulla. Note that data for 40 days of gestation represent
binding in the whole mesonephros and metanephros, since the mesone-
phros has no medulla and in the metanephros cortex and medulla are
ill-defined.
At least four effects of Ang II mediated by AT2 receptors have
been proposed. It has been reported [341 that in the normal adult
rat kidney activation of the AT2 receptor mediates cyclic
guanosine monophosphate (cGMP) production, which partially
inhibits the prostaglandin production stimulated by activation of
the AT1 receptor. Ovulation in the rabbit ovary can be induced by
exposure to Ang II and has been claimed to be mediated via the
AT2 receptor [35]. In cells of neuronal origin (PCI2W cells) Ang
II, via the AT2 receptor, has been shown to inhibit proliferation
and promote differentiation [36J. Finally, Kakuchi et a! [171 have
proposed that expression of the AT2 receptor in the developing
mouse kidney may be a signal to delineate those cells that will
undergo apoptosis after nephrogenesis is complete. In an isolated
cell culture system it is claimed that Ang II, acting on the AT2
receptor, does induce apoptosis [371. While this may indeed be
part of the function of the mesenchymal expression of AT2, it
cannot apply to the macula densa expression, as the macula densa
persists.
The macula densa is a specialized area of the tubule joining the
thick ascending limb of the loop of Henle to the distal tubule. It
is specifically and invariantly located at the vascular pole of the
glomerulus. It has a distinctive morphology and expresses a
specific fibronectin receptor (13 integrin 6), nitric oxide synthase I
and cyclooxygenase 2. It is sensitive to the chloride concentration
of the filtrate and is thought to mediate tubuloglomerular feed-
back and modulate renin secretion [38, 391. The presence of the
AT2 receptor mRNA in the niacula densa throughout, but not
after, the period of nephrogenesis may imply a role for Ang II and
this receptor in fixing the position of the macula densa segment.
One may postulate that either Ang II via the AT2 receptor
stimulates the production of some adhesion molecules, or that
AT2 receptor, via the AT1 receptor, prevents the action of Ang II
for the proliferation and downward shift of the epithelial struc-
tures that will go to form the loop of Henle.
Mice lacking the AT2 receptor have been produced by homol-
ogous recombination and no renal abnormalities have been
detected [40, 411. However, the kidneys were not examined
extensively, and most renal development occurs after, not before
birth in mice. There may be some species variation in Ang II
action, via the AT2 receptor, in developing kidneys.
It has been shown that the concentration of renal AT1 mRNA
in the ovine fetus is higher during the last third of gestation than
in the two-week-old neonate [20, 21], and our results confirm and
extend this observation to younger ages. The renal AT2 mRNA
concentrations were higher in ovine fetuses at 60 to 90 days of
gestation than in the last third of gestation [20]. When fetal
plasma cortisol concentrations were increased substantially (30-
fold) at 130 days of gestation, by a 48 hour infusion of cortisol,
there was a small but significant decrease in renal AT1 mRNA
concentration, but no change in renal AT2 mRNA abundance. On
the other hand, a smaller (2.5-fold) increase in plasma Ang II
concentration, achieved by infusion of Ang 11(10 jig/hr for 24 hr)
caused small but significant decreases in both AT1 and AT2
mRNA in the fetal kidney [20, 211.
The effects of Ang II, in the fetal kidney are different from
those in the adult kidney, where blockade of AT1 receptors results
in an increase in GFR, and a decrease in proximal tubule sodium
reabsorption without significant changes in renal blood flow [291.
Ang II, in the late gestation ovine fetal kidney, is necessary for the
maintenance of glomerular filtration rate as long-term captopril
treatment causes a reduction in GFR, and this can be reversed by
exogenous Ang 111421. When endogenous Ang II levels are raised
there is a diuresis and natriuresis due, in part, to a depression of
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Fig. 5. In vitro autoradiographic localization of AT5 and AT2 receptor binding in ovine fetal kidney (—100 days). (A) Total Ang II receptor binding.
(B) Non-specific binding in the presence of 1 j.M unlabeled Ang II. (C) AT1 receptor binding in the presence of 10 sM of the AT2 receptor antagonist,
PD 123319. (D) AT2 receptor binding in the presence of 10 ILM of the AT1 receptor antagonist, losartan.
proximal tubular sodium reabsorption [43]. Within the glomeru-
lus, exclusively AT1 receptors were present, as found in the adult
of all species investigated. In the early gestation ovine fetus, which
is at the same stage of morphogenesis as the neonatal rat, the
presence of AT1 receptors in the interstitium may be necessary for
development of the loop of Henle structure and maturation of the
inner stripe of the outer medulla.
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